A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets
Clinical trial NCT06972498 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06972498
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-12-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.